Key result
Established and novel risk factors guide HCM progression, but risk stratification remains challenging.
Answers are grounded in this paper and cite their sources.
Reviews established and novel risk factors for disease progression and sudden cardiac death in hypertrophic cardiomyopathy, highlighting ongoing challenges in clinical risk stratification.
Hypertrophic cardiomyopathy (HCM) is one of the important causes of sudden cardiac death (SCD) in younger people and athletes. It is important to identify the risk factors for SCD in individuals with HCM. This article, based on recent systematic literature studies, will focus on the risk factors for progression in patients with HCM. The article discusses the established risk factors, such as a family history, unexplained syncope, and some new risk factors. The findings of this article demonstrate that there is a need for further research on individual risk factors and risk stratification in HCM patients remains a clinical challenge.
No takes yet. Share an insight, caveat, or question.
Sengupta et al. (2026) conducted a review in Hypertrophic cardiomyopathy (HCM). Risk factors for progression (including family history, unexplained syncope, and novel risk factors) was evaluated on Disease progression and sudden cardiac death (SCD). Established and novel risk factors such as family history and unexplained syncope are discussed for HCM progression, though risk stratification remains a clinical challenge.
Synapse has enriched 10 related papers. Consider them for comparative context: